Figure 4.
Stable infection of CAD5 cells reconstituted with Mo-PrP and BV-PrP by 22 L prions. (a) Immunoblot analysis demonstrating sustained infection phenotype of reconstituted MoPrP cells. Control CAD5 cells (C) and cells reconstituted with mouse PrP (CAD5_Mo) were infected with 1% brain homogenate from terminal ill mice infected with 22 L prions (CAD5_Mo_22 L). Cell lysates from passage P3 of parental CAD5 and passages P3 and P9 of the CAD5_Mo_22L cells were treated with and without proteinase K. The non-treated (−PK) represents the total PrP (left panel) while the treated lysate (+PK) represents PrPSc (right panel). The reconstituted CAD5-Mo cells show presence of PrPSc from passage P3 to P9 post-infection, demonstrating successful and persistent infection. (b) Immunoblot analysis demonstrating sustained infection of CAD5 KO cells reconstituted with bank vole PrP (CAD5_BV). Control CAD5 (C) and the CAD5_BV cells were incubated with 1% brain homogenate from mice infected with 22L prions (CAD5_BV_22L) and processed as above. The reconstituted CAD5_BV cells showed presence of PrPSc from passage P3 to P9 post-infection (right panel), demonstrating successful and persistent infection.